New!
RHA Redensity Logo

Fined-tuned finish for moderate to severe dynamic perioral rhytids

The first and only FDA-approved filler for injection into both the superficial dermis and dermis to treat dynamic perioral rhytids.

May be appropriate for patients who:
  • Need correction with a superficially placed filler in the dermis
  • Desire a natural look and feel without unwanted heaviness

Results that last up to

12 months*

Results that last up to 12 months*

Patient was treated with 0.3 mL RHA Redensity™ in perioral rhytids; 1.9 mL RHA® 3, including 1.0 mL in nasolabial folds, 0.5 mL in marionette lines, and 0.4 mL in oral commissures; and 1.6 mL RHA® 4 in the nasolabial fold area. Images captured before and two weeks after treatment. Results may vary.

*Clinical effectiveness and safety were demonstrated in a 12-month clinical trial for the treatment of moderate to severe perioral rhytids.

RHA REDENSITY™ INJECTION

Indicated for injection into the dermis and superficial dermis of the face, for the correction of moderate to severe dynamic perioral rhytids in adults 22 or older

  • Thin gauge needle (30 G x ½)
  • Inserted into superficial dermis or dermis using serial puncture, linear threading or fanning, raising a wheal with needle bevel at 5° to 15° angle to the skin surface
RHA Redensity injection at the superficial dermis compared to the other gels
OTHER PRODUCTS